Corsano CardioWatch not only analyses heartbeat and heart rhythm. The A-Fib algorithm has been validated in clinical studies and detects irregular heartbeats (e.g. extrasystoles) as well as the presence of absolute arrhythmia with suspected atrial fibrillation (AF).
Corsano is in the process to medically certify a new software platform. Latest technologies have been applied and the SW Development Process has been meticulously documented for CE-MDR and FDA Certification.